On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- The airway in asthma is remodelled
- Asthmatic and non-asthmatic airways
- Big breakthrough in 2001
- Asthmatic and non-asthmatic cell growth
- Asthmatic Airway Smooth Muscle (ASM) cells
- Airway smooth muscle and ECM
- ECM production
- Fibronectin expression with beclomethasone
- Wound repair
- Wound closure in asthmatic & non-asthmatic cells
- TGFbeta and ASM
- CTGF induction in bronchial segments
- Altered matrix production
- TGFbeta induces collagen and fibronectin mRNA
- TGFbeta influence on non-asthmatic tissue
- Human airway smooth muscle
- CTGF influence on non-asthmatic tissue
- TGFbeta signalling pathways
- TGFbeta signalling pathways- pSMAD2
- TGFbeta signalling pathway- CTGF
- TGFbeta signalling pathways- collagen
- TGFbeta signalling pathways- fibronectin
- TGFbeta signalling
- Effect of current therapies- corticosteroids
- Effect of current therapies- beta2 agonists
- Roflumilast
- Bronchial rings
- Conclusions so far
- Increased fibulin-1 may mediate airway remodelling
- Fibulin-1
- Fibulin-1 increased in vivo
- No difference in basal fibulin 1C or 1D mRNA
- TGFbeta induces increased fibulin-1C mRNA
- TGFbeta induces increased fibulin-1 protein (1)
- TGFbeta induces increased fibulin-1 protein (2)
- TGFbeta induces increased fibulin-1 in ECM
- Fibulin-1C antisense decreases fibulin-1 in ECM
- Fibulin-1 in ASM involved in wound repair
- Fibulin-1 promotes proliferation of ASM
- Fibulin-1 does not alter migration of ASM
- Fibulin-1 regulates airway hyper-responsiveness
- Fibulin-1 future goals
- Thanks
Topics Covered
- Remodelling of the asthmatic airway
- Airway smooth muscle (ASM)
- increased deposition of matrix proteins
- Asthma increases ASM
- Characteristics of ASM cells in non-asthmatics
- Characteristics of ASM in asthmatics
- ASM produces extracellular matrix (ECM) proteins
- Differences in ECM in asthmatics
- Fibulin-1 in asthma
- Fibulin as a therapeutic target
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Black, J. (2011, December 29). The airway smooth muscle in asthma [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/JXLI5646.Export Citation (RIS)
Publication History
- Published on December 29, 2011
Financial Disclosures
- Prof. Judith Black has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.